期刊文献+

增殖细胞核抗原和p16蛋白表达与鼻咽癌放射敏感性相关性研究 被引量:1

Relationship between the expression of PCNA and p16 protein and the radiosensitivity of nasopharyngeal carcinoma
原文传递
导出
摘要 目的探讨增殖细胞核抗原(PCNA)和p16蛋白表达与鼻咽癌放射敏感性的关系。方法应用免疫组化法,检测63例初行放疗前鼻咽癌组织中PCNA和p16蛋白表达情况。结果63例鼻咽癌组织中PCNA和p16蛋白表达阳性者分别有62例(98.41%)和13例(20.63%),高表达者分别有22例(34.92%)和7例(11.11%);鼻咽癌组织中PCNA表达与p16蛋白表达呈负相关(rs=-0.79,P〈0.01);PCNA及p16蛋白阳性表达水平越高,则鼻咽癌对放射治疗越敏感,放疗后鼻咽局部癌肿完全消退率越高(P〉0.05);PCNA和p16蛋白同时高表达者比单一指标高表达者,对放射敏感性更高(P〈0.05)。结论PCNA和p16蛋白是反映鼻咽癌放射敏感性和预测其放疗疗效的重要指标,在作为放疗敏感性的指标上,PCNA可能较p16更有意义。 Objective To investigate the relationship between the expression of PCNA and p16 protein and the radiosensitivity of nasopharyngeal carcinoma (NPC). Methods PCNA and p16 protein expression were detected by immunohistochemistry method in 63 biopsy specimens before radiotherapy of NPC. Results The rates of PCNA and p16 protein expression were 98.41% (62/63) and 20. 63 % ( 13/ 63) respectively. The rates of PCNA and p16 protein high expression were 34. 92% (22/63) and 11.11% (7/63) respectively. The expression of PCNA and p16 protein were hightly correlated ( r, = - 0. 79, P 〈 0. 01 ) . The higher the expression of PCNA and p16 protein were, the higher the radiosensitivity of NPC was, and the better the curative effect was( P 〈0. 05). Furthermore the radiosensitivity of NPC was higher in the cases with high expression of beth PCNA and p16 protein than that in the cases with the high expression of either PCNA or p16 protein ( P 〉 0. 05 ) ,Conclusion PCNA and p16 protein were the important indicators for the radiosensitivity of NPC and the effect of radiotherapy.
出处 《中国医师杂志》 CAS 2007年第5期619-621,共3页 Journal of Chinese Physician
关键词 鼻咽肿瘤/放射疗法 增殖细胞核抗原 蛋白质P16 Nasopharyngeal neoplasms/radiotherapy Proliferating cell nuclear antigen Protein p16
  • 相关文献

参考文献7

  • 1Maohuai C, Joseph CKL,Shikyuen L. AgNORsquantitative assessment of cancer cell populations in undifferentiated nasopharyngeal carcinoma. AanlytQuant Cytol Histol,2002,24( 2 ) :89.
  • 2Okuno Y, Nishmura Y, Kashu I, et al. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki267 for radiotherapy of esophageal squamous cell carcinomas. Br Cancer, 1999,80( 3 - 4) :387.
  • 3Desai GR, Myerson R J, Higashikubo R, et al. Carcinoma of the rectum possible cellular predictors of metastatic potential and response to radiation therapy. Dis Colon Rectum, 1996,39(10) : 1090.
  • 4罗京伟,徐国镇,杨伟志,高黎,余子豪,殷蔚伯.增殖细胞核抗原的表达和鼻咽癌的临床相关性研究[J].中华放射肿瘤学杂志,1997,6(3):170-173. 被引量:20
  • 5Okamoto A, Demet rick DJ,Spmare EA, et al. Mutations and altered expression of P16 ( 1N K4) in human cancer. P roc N at IA cad Sci USA, 1994,19 : 11045.
  • 6Lo KW,Huang DP,Lau KM, et al. 1 P16 gene alter2 at ions in nasopharyngeal carcionmal Cancer Res, 1995,53 : 2039.
  • 7陈一招,徐如祥,郑景熙,张云.p16基因对脑胶质瘤细胞生长及放射敏感性的影响[J].中国临床神经科学,2000,8(3):192-194. 被引量:2

二级参考文献2

共引文献20

同被引文献22

  • 1张燕,涂文勇.非小细胞肺癌p16基因表达与放疗敏感性的关系[J].临床肿瘤学杂志,2005,10(6):637-639. 被引量:1
  • 2Freytag SO, Strieker H, Pegg J, et al. Phase I study of replication- competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed interme- diate-to high-risk prostate cancer. Cancer Res, 2003, 63 (21): 7497-7506.
  • 3Han JA, Kim JI, Ongusaha PP, et al. P53-mediated induction of Gox-2 counteracts p53-or genotoxic stress-induced apoptosis. EMBO J, 2002, 21(21): 5635-5644.
  • 4Collis S J, DeWeese TL. Enhanced radiation response through directed molecular targeting approaches. Cancer Metastasis Rev, 2004, 23(3-4): 277-292.
  • 5Baker SJ, Markowitz S, Fearon ER, et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science, 1990, 249(4971): 912-915.
  • 6Hanpt S, Haupt Y. Importance of p53 for cancer onset and therapy. Anticancer Drugs, 2006, 17(7): 725-732.
  • 7Mimeault M, Batra SK. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. Carcinogenesis, 2006, 27(1): 1-22.
  • 8Guha A, Mukherjee J. Advances in the biology of astrocytomas. Curt Opin Neurol, 2004, 17(6): 655-662.
  • 9Moon C, Oh Y, Roth JA. Current status of gene therapy for lung cancer and head and neck cancer. Clin Cancer Res, 2003, 9(14): 5055-5067.
  • 10Lavin MF, Khanna KK. ATM: the protein encoded by the gene mutated in the radiosen-sitive syndrome ataxia-telangiectasia. Int J Radiat Biol, 1999, 75(10): 1201-1214.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部